Resmed (RSMDF) Intangibles (2010 - 2026)

Resmed has reported Intangibles for 14 years, with the latest figure at $425.2 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 1.14% year-over-year to $425.2 million; the trailing twelve-month figure through Mar 2026 stood at $425.2 million (down 1.14% YoY), and the FY2025 full-year result was $464.9 million, down 4.33% from the prior year.
• Intangibles for Q1 2026 stood at $425.2 million, down from $430.2 million in the prior quarter.
• The five-year high for Intangibles was $586.9 million in Q4 2022, with the low at $338.2 million in Q3 2022.
• Historically, Intangibles has averaged $467.1 million across 5 years, with a median of $464.9 million in 2025.
• Annual changes were most pronounced in 2023 — Intangibles soared 66.58% — and 2024, when it dropped 17.07%.
• Resmed's Intangibles stood at $586.9 million in 2022, then fell by 10.0% to $528.2 million in 2023, then slipped by 17.07% to $438.0 million in 2024, then dropped by 1.77% to $430.2 million in 2025, then dropped by 1.17% to $425.2 million in 2026.
• The last three Intangibles figures came in at $425.2 million (Q1 2026), $430.2 million (Q4 2025), and $447.1 million (Q3 2025), per Business Quant data.